Imagine waking up every morning and having a device that greets you with a report on the quality of your sleep, a summary of your key health indicators, and a schedule of suggested exercises for the day tailored to your age, health and personal goals. Although a device with features like this might sound like science fiction, Professor John A. Rogers and his research team at Northwestern University are working to make this vision a reality.

Who Is John A. Rogers?

Dr. John A. Rogers is Professor of Materials Science and Engineering, Biomedical Engineering, and Neurological Surgery at Northwestern University. He is a leading materials science researcher creating “flexible organic electronics” that can be applied to the skin or implanted inside the human body. Some of these electronic devices will provide a steady stream of health information to patients and their doctors. Other devices will administer electrical therapy to injured parts of the body, for example, to stimulate repair of damaged nerves in spinal cords.

Rogers grew up in a science-focused family. His father has a Ph.D. in physics, and his mother is a poet whose poetry explores science and nature. As a sophomore in high school, his interest in chemistry was piqued by a homework assignment requiring students to write a one-page summary on each of the elements of the periodic table. Rogers was fascinated by the fact that elements having such different characteristics were all composed of the same three fundamental building blocks: protons, neutrons and electrons. All that varied were the number and configuration of these building blocks in each element. Rogers’s work today focuses on how the number and configuration of atoms and molecules affect the properties of materials whether the materials can be effectively and safely applied to, or implanted inside, the human body.

Continue reading “Wearable and Implantable Electronic Devices to Monitor Health and Treat Disease – CHICAGO’S NEW SILICON PRAIRIE”

By Sanford (Sandy) Morganstein

Book Review for The Day AI Becomes God by Tetsuzo Matsumoto

In the context of artificial intelligence (AI) the “singularity” refers to a fundamentally transformative time when AI becomes intelligent enough to improve itself without human assistance.  When AI can improve itself, the self-improvement process leads to runaway computer-based technology that will radically change civilization.  Improvement tirelessly builds on improvement leading to capabilities we can hardly imagine.

Tetsuzo Matsumoto has an excellent vantage point to observe the (probable) coming of the singularity and the consequences of it.  While not a technologist himself, Matsumoto has been present at the birthing table of many of the advanced technologies that have become part of daily life.  Matsumoto was on the board of Softbank, was president and chairman of Qualcomm Japan and a senior executive at one of the largest Japanese trading companies where part of his responsibilities was to monitor emerging technology with an eye to commercialization.

Continue reading “Book Review for The Day AI Becomes God”

Watch the full program here.

 

A recent breakthrough in our war against cancer is the development of therapies that harness our body’s immune system to seek out and destroy tumor cells. While such immunotherapies have significantly prolonged the life of some patients who had previously exhausted all treatment options, the majority of cancer patients still do not benefit from existing immunotherapies. Thus, there is an urgent need to devise new therapies that can benefit a larger population of cancer patients. A better understanding of the body’s immune system is also very important for the prevention and treatment of a growing list of autoimmune and inflammatory diseases, such as lupus, arthritis and neurodegenerative diseases. In these diseases, the immune system misfires and attacks our own tissues. Our immune system is also crucial for defending us from infections by a large variety of microbial pathogens, such as viruses, bacteria, and parasites.

Watch the Q&A portion here.

 

A recent breakthrough in our war against cancer is the development of therapies that harness our body’s immune system to seek out and destroy tumor cells. While such immunotherapies have significantly prolonged the life of some patients who had previously exhausted all treatment options, the majority of cancer patients still do not benefit from existing immunotherapies. Thus, there is an urgent need to devise new therapies that can benefit a larger population of cancer patients. A better understanding of the body’s immune system is also very important for the prevention and treatment of a growing list of autoimmune and inflammatory diseases, such as lupus, arthritis and neurodegenerative diseases. In these diseases, the immune system misfires and attacks our own tissues. Our immune system is also crucial for defending us from infections by a large variety of microbial pathogens, such as viruses, bacteria, and parasites. Key to our understanding of the immune system is how it detects microbial pathogens and cancer cells and how it avoids attacking our own tissues in normal situations. An important mechanism of this immune detection is the detection of DNA from microbial pathogens and cancer cells. Our lab discovered the DNA sensing enzyme cGAS and the pathway through which cGAS launches immune and autoimmune responses. Dr. Chen will discuss the current status of immunotherapies and describe efforts in harnessing the cGAS pathway to fight cancer and autoimmune diseases.

 

This program is generously supported by the Ann Lurie Trust.

By Xiaoyi Liu

 

Sci-fi humanoids such as the Terminator or the cyber-agents in The Matrix often come to mind as artificial intelligence moves our cars, gadgets and social networks and in new directions.

But for computing innovator Rick Stevens, associate lab director at Argonne National Laboratory, AI means accelerating fast-thinking computers that could reveal clues to the treatment of diseases such as cancer.

Continue reading “The Future of Artificial Intelligence”

Read the original article here.

 

MARTINSBURG — Girl Scouts Nation’s Capital this week has named three women from the Eastern Panhandle as the 2019 Women of Distinction.

They will be recognized at the 15th annual Women of Distinction luncheon this fall on Oct. 9 at the Holiday Inn in Martinsburg.

Nominated by community members, Dr. Mary J.C. Hendrix, Christina Johnson and Audrey Morris were selected by their peers for outstanding volunteerism in the community, contributions to their professions, and being exemplary role models for girls, according to a release from the Girl Scouts Nation’s Capital.

“They each clearly epitomize this year’s theme for the Girl Scouts’ Gold Award: ‘Girls the World Needs,’” the release said.

Dr. Mary J.C. Hendrix is Shepherd University’s 16th president and its first graduate ever to lead the school; her undergraduate degree was in pre-med/biology. She holds a Ph.D. from George Washington University in anatomy and was a National Institute of Health Postdoctoral Research Fellow at Harvard Medical School in anatomy/cell biology. Hendrix is currently on the Board of Directors at the Annenberg Center for Health Sciences; she chairs the National Disease Research Interchange Board, which is partially funded by NIH; she serves on the Board of Directors for Research!America, a not-for-profit public education and advocacy alliance working to make health research a higher national priority; and also serves on the Chicago Council for Science and Technology, and the Executive Advisory Board for Northwestern University Center of Cancer Nanotechnology Excellence. Additionally, she serves locally on the Meritus Medical Center’s Board of Directors in Hagerstown.

Continue reading “Girl Scouts announce 2019 Women of Distinction”